Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
- Conditions
- Meningitis, CryptococcalHIV Infections
- Registration Number
- NCT00002019
- Lead Sponsor
- Liposome
- Brief Summary
To evaluate the safety, tolerance and efficacy of three different dosage regimens of Amphotericin B Lipid Complex (ABLC) compared to Fungizone (Amphotericin B) in patients with AIDS and cryptococcal meningitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (19)
Harbor - UCLA Med Ctr
🇺🇸Torrance, California, United States
Dr Thomas Patterson
🇺🇸New Haven, Connecticut, United States
Walter Reed Army Med Ctr
🇺🇸Washington, District of Columbia, United States
Rush Presbyterian - Saint Luke's Med Ctr
🇺🇸Chicago, Illinois, United States
Natl Naval Med Ctr
🇺🇸Bethesda, Maryland, United States
Univ Hosp
🇺🇸Boston, Massachusetts, United States
East Orange Veterans Administration Med Ctr
🇺🇸East Orange, New Jersey, United States
Saint Michael's Med Ctr
🇺🇸Newark, New Jersey, United States
Beth Israel Med Ctr / Peter Krueger Clinic
🇺🇸New York, New York, United States
Dr Dorothy Friedberg
🇺🇸New York, New York, United States
Scroll for more (9 remaining)Harbor - UCLA Med Ctr🇺🇸Torrance, California, United States